ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2017

Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis.

Alberto Mazza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.